There is no need to emphasize the overwhelming importance of p53 for crucial cellular processes and of genetic alterations resulting from its loss of function or a dominant oncogenic mutant in many human cancer types. These functions are well described and include control of cell cycle progression, apoptosis, senescence, DNA-repair mechanisms and autophagy [1] .
A new page in the huge book of p53 was opened in a recent publication by Chang et al. by linking p53 to the control of an epithelial-mesenchymal transition (EMT) and its associated effects [2] . EMT is a key program in embryonic development and is conferred by so-called EMT activators, transcriptional repressors, such as Snail and ZEB family members, which suppress expression of epithelial genes. Its aberrant activation in cancer cells induces malignant tumor progression, invasion, dissemination and finally metastasis, due to acquisition of an abnormal cellular motility [3] . Recently, EMT was also linked to an activation of stemness properties, thereby conferring a combined stemness and motility phenotype to cancer cells [4] . Thus aberrant EMT might induce a subpopulation of "Migrating Cancer Stem Cells" as potential source of metastasis [5] . At molecular level EMT activators were shown to suppress transcription of all five members of the miR-200 family of microRNAs, located in two clusters on Chr. 1 (miR-200a, b and 429) and Chr. 12 (miR-141 and 200c) [6, 7] . In turn, miR-200 members inhibit translation of EMT-activators, particularly ZEB factors, thereby inducing the reverse process of a mesenchymal-epithelial transition (MET) [7] [8] [9] [10] . Thus, miR-200 and ZEB1 factors are linked in a reciprocal feed-back loop, which controls an immense phenotypic flexibility and plasticity [11] . The range of this plasticity became clear, when it was shown that miR-200 not only counteracts classical EMT properties like cell motility, but also suppresses translation of stem cells factors, such as BMI1 [12, 13] . Accordingly, miR-200 family members were shown to be down-regulated in breast cancer stem cells and normal breast epithelial stem cells [12] .
Due to the strong potency of miR-200 family members, in particular miR200c, to control crucial cellular processes, such as motility and stemness, its own regulators play an important role. Although EMT activators, particularly ZEB factors, were already identified as transcriptional repressors of miR-200 genes, their activating pathways were still undefined. This gap was closed in the publication by Chang et al. [2] , showing that p53 is a transcriptional activator of the miR-200c gene ( Figure 1 [14] . Moreover it was already shown that microRNAs are involved in the control of other p53-dependant functions. Several groups demonstrated that cell cycle arrest, apoptosis and senescence can be triggered by p53-induced transcriptional activation of the microRNAs, miR-34a and miR-34b/c [15] . Besides its obvious role in tumor progression the results also indicate a physiological role of the p53/miR-200c link. Is p53-mediated activation of miR-200c essential for the control of stemness vs. differentiation during embryonic development of epithelial tissues and for their adult homeostasis? Further work should address these issues.
One result of the publication, showing that both overexpression of dominant active mutant p53, as well as depletion of normal WT p53, leading to its complete loss of function, can inhibit miR-200c expression and its associated functions, raises additional questions. This stands in contrast to many publications describing specific oncogenic effects of mutant p53 in human cancers, which can not be achieved by a complete p53 loss. For instance, only mutant p53, not a complete loss, promotes invasion and metastasis in a genetic mouse model of pancreatic cancer, whereas the complete loss of p53 also induces an escape of senescence and growth arrest [16] . This indicates that other, additional mechanisms of dominant p53 mutations in driving EMT, tumor invasion and metastasis must exist. Again the control of microRNA function might be involved: WT p53 activates only one of the two miR-200 clusters. How is the second cluster activated, and more importantly how it is inactivated in tumors with mutated p53? Is it only due to aberrant activation of EMT inducers, such as ZEB1? Or are additional effects of mutant p53 involved? Cancers often show a general decline in microRNA maturation and expression, which might be due to a functional suppression of microRNA maturation factors. Recently p53 was shown to enhance microRNA maturation by associating with Drosha [17] . Has mutant p53 a dominant function in inhibiting microRNA maturation, which cannot be exerted by a simple complete loss of p53 function? Further work should address, if this is another 
